These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 30553446

  • 21. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
    Wang C, Ye M, Zhao Q, Xia M, Liu D, He L, Chen G, Peng Y, Liu H.
    Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
    [Abstract] [Full Text] [Related]

  • 22. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.
    Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.
    Kidney Blood Press Res; 2008; 31(1):29-37. PubMed ID: 18182777
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. IgA nephropathy and tonsils--an approach from the structure of IgA1 produced by tonsillar lymphocytes.
    Hiki Y, Horie A, Yasuda Y, Iwase H, Sugiyama S.
    Acta Otolaryngol Suppl; 2004 Dec; (555):28-31. PubMed ID: 15768794
    [Abstract] [Full Text] [Related]

  • 25. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Dec; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 26. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.
    Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
    [Abstract] [Full Text] [Related]

  • 29. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 30. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H.
    Adv Otorhinolaryngol; 2011 Oct; 72():68-70. PubMed ID: 21865693
    [Abstract] [Full Text] [Related]

  • 33. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
    Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):268-74. PubMed ID: 10777713
    [Abstract] [Full Text] [Related]

  • 34. Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
    Sun Q, Zhang Z, Zhang H, Liu X.
    PLoS One; 2016 Apr 29; 11(11):e0166700. PubMed ID: 27870872
    [Abstract] [Full Text] [Related]

  • 35. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
    Takahashi K, Wall SB, Suzuki H, Smith AD, Hall S, Poulsen K, Kilian M, Mobley JA, Julian BA, Mestecky J, Novak J, Renfrow MB.
    Mol Cell Proteomics; 2010 Nov 29; 9(11):2545-57. PubMed ID: 20823119
    [Abstract] [Full Text] [Related]

  • 36. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 29; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 37. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
    Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J.
    Kidney Int; 1997 Aug 29; 52(2):509-16. PubMed ID: 9264010
    [Abstract] [Full Text] [Related]

  • 38. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
    Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.
    J Biol Chem; 2005 May 13; 280(19):19136-45. PubMed ID: 15728186
    [Abstract] [Full Text] [Related]

  • 39. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
    Kokubo T, Hashizume K, Iwase H, Arai K, Tanaka A, Toma K, Hotta K, Kobayashi Y.
    Nephrol Dial Transplant; 2000 Jan 13; 15(1):28-33. PubMed ID: 10607764
    [Abstract] [Full Text] [Related]

  • 40. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug 13; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.